Successful Treatment of Hepatitis C Virus by Ledipasvir/Sofosbuvir in a Cirrhotic Patient with Sickle Cell Disease and Thalassemia Minor

Around 8% of patients diagnosed with sickle cell disease (SCD) are hepatitis C virus (HCV) carriers. Previously, HCV treatment was seldom considered in SCD patients, as the ribavirin-induced hemolysis and interferon-induced cytopenias could lead to more profound anemia. Nowadays, several oral direct...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Moussawi, Hassan, Polavarapu, Abhishek D., Asti, Divya, Awada, Zainab, Mulrooney, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244097/
https://www.ncbi.nlm.nih.gov/pubmed/30483041
http://dx.doi.org/10.1159/000493421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244097/
https://www.ncbi.nlm.nih.gov/pubmed/30483041
http://dx.doi.org/10.1159/000493421

Ejemplares similares